Wastewater Biomarkers for Community Infection Surveillance

Abstract

Wastewater-based epidemiology (WBE) has emerged as a crucial tool for the surveillance of infectious diseases within communities. By quantifying specific biomarkers in sewage, healthcare professionals can estimate disease prevalence, monitor outbreaks, and guide public health interventions. This review synthesizes recent scientific advancements, clinical relevance, and guideline recommendations regarding the use of wastewater biomarkers for infection surveillance, with a focus on mechanisms, practical applications, and future directions.

Introduction

The concept of wastewater-based epidemiology leverages the collective biological output of a population to monitor public health threats. With the advent of sensitive molecular techniques, community-level surveillance of infections such as SARS-CoV-2, enteric viruses, and antimicrobial resistance genes has become feasible and actionable. This methodology offers a non-invasive, cost-effective, and timely approach to detecting infectious agents before clinical cases overwhelm healthcare systems, making it a compelling adjunct to traditional surveillance methods.

Epidemiology / Disease Burden

Infectious diseases remain a significant burden globally, with outbreaks often spreading undetected until symptomatic cases arise. COVID-19 demonstrated the limitations of symptom-based surveillance and the need for early detection systems. Wastewater biomarkers have proven effective in tracking SARS-CoV-2, norovirus, hepatitis A, and other pathogens at the community level, allowing for an understanding of infection dynamics, seasonality, and hotspots. Published studies from multiple countries show strong correlation between viral RNA concentrations in wastewater and reported case numbers, demonstrating the epidemiological validity of this approach.

Pathophysiology

Pathogens and their genetic material are excreted in human waste, either as intact organisms or nucleic acid fragments. These biomarkers enter wastewater systems, where they can be concentrated and detected using polymerase chain reaction (PCR), digital PCR, and next-generation sequencing. For example, SARS-CoV-2 RNA is shed in feces and urine, entering sewers even before individuals become symptomatic. The stability of these markers in wastewater varies, influenced by environmental factors such as temperature, pH, and chemical composition, which must be accounted for in surveillance protocols.

Risk Factors

Community-level risk factors influencing the utility of wastewater surveillance include population density, sewer infrastructure, and the prevalence of asymptomatic infections. Populations with high rates of asymptomatic or mild disease forms may be underrepresented in clinical reporting but adequately captured through WBE. Socioeconomic factors, sanitation practices, and local disease epidemiology also modulate the concentration and detectability of biomarkers in sewage, necessitating site-specific calibration of surveillance systems.

Clinical Features

Unlike clinical surveillance, which identifies symptomatic individuals, wastewater surveillance captures both symptomatic and asymptomatic cases. This provides a more comprehensive assessment of community infection status. For pathogens like SARS-CoV-2 and norovirus, fecal shedding can precede or outlast respiratory symptoms, making wastewater biomarkers a leading indicator for emerging outbreaks and a trailing indicator for sustained transmission.

Diagnosis

Diagnosis via wastewater biomarkers involves the collection of representative sewage samples, extraction of nucleic acids, and detection using sensitive molecular assays. Quantitative PCR and digital PCR techniques allow for the estimation of viral or bacterial loads, which can be normalized to population size or chemical markers of human waste (e.g., crAssphage). High-throughput sequencing enables the detection of novel pathogens and antimicrobial resistance genes, adding further depth to community health assessments.

Treatment & Management

While WBE does not treat infections directly, its role in informing public health responses is substantial. Early detection of pathogen spikes in wastewater can prompt targeted clinical testing, isolation, and resource allocation. Wastewater data can also guide vaccination campaigns, school closures, and travel advisories. Integrating WBE with clinical data enhances situational awareness and enables dynamic, data-driven management of infectious disease threats.

Recent Advances / Emerging Therapies

Recent innovations include multiplex assays capable of detecting multiple pathogens simultaneously, real-time data dashboards, and machine learning algorithms for outbreak prediction. Portable field-deployable platforms are under development, allowing for rapid, decentralized surveillance. Advances in metagenomics have enabled the detection of emerging pathogens and quantification of viral variants, antimicrobial resistance, and even population-level immune responses. These technologies are rapidly being incorporated into national surveillance frameworks and global health initiatives.

Guideline Recommendations

International and national health agencies, including the CDC, WHO, and ECDC, now recommend integrating wastewater surveillance into pandemic preparedness and routine infectious disease monitoring. Guidelines emphasize standardized sampling, quality control, data interpretation, and ethical considerations regarding privacy. Cross-sector collaboration between public health, environmental, and laboratory services is essential for effective implementation. The adoption of WBE is particularly encouraged in resource-limited settings, where clinical testing capacity may be insufficient.

Conclusion

Wastewater biomarkers are transforming community infection surveillance by providing early, population-wide insights into disease prevalence and transmission dynamics. As technologies advance and guidelines mature, WBE is poised to become an indispensable tool for public health practitioners, complementing clinical data and enhancing outbreak preparedness. Ongoing research, cross-disciplinary collaboration, and continued investment will further refine its utility and impact in the fight against infectious diseases.